Queen's researchers receive more than $1.8 million in research infrastructure funding from Canadian Foundation for Innovation.
Ten Queen's University researchers have received more than $1.8 million in combined funding from the Canadian Foundation for Innovation (CFI) John R. Evans Leaders Fund. The fund supports researchers by providing the foundational research infrastructure required to undertake leading-edge research. The investment will allow for advanced research in a variety of fields - from cancer research to new materials for use within nuclear reactors.
"The investment announced today from the John R. Evans Leaders Fund is crucial to ensuring Queen's researchers have the infrastructure necessary to remain on the leading edge of investigation," says Dr. John Fisher, Queen's Interim Vice-Principal (Research). "This funding will allow our researchers to train qualified personnel, collaborate with colleagues across Canada and around the world, and make important new developments in their fields."
The following Queen's researchers have received funding:
Lois Mulligan's (Cancer Research Institute) research is focused on uncovering signals that contribute to the spread of cancer with the aim of developing new treatments to counteract these signals. To support this research, she has received $124,040 to fund the purchase of new imaging technology that will allow her to track cancer cell motility and tumor growth in real time.
Janet Dancey (Canadian Cancer Trials Group) has received $197,065 to support the acquisition of a digital histology slide scanner. The scanner will allow CCTG to share digitized scans of slides prepared from tumour specimens to allow expert pathologists across Canada to contribute their expertise in diagnosis and classification of tumours, as well as to detect and quantify new biomarkers that could lead to improved treatments.